The Power Of Clinical Trial Supply Visibility
Over the last few years the number of innovative drugs brought to market has declined as pharmaceutical companies have focussed their resources on improvements to existing drugs or expanding their off-label use.
In part, the evolution of this trend can be traced to the advent of corporate mergers between pharmaceutical companies which has left much of the innovation gap in new medications to be filled by biopharma. Indeed, it is from these relatively small companies that the majority of new products and innovations have emerged in recent years…
October 12, 2015